Categories: News

Corscience Joins AdvaMed to Drive Innovation in Medical Technology

ERLANGEN, Germany–(BUSINESS WIRE)–German medical technology development service provider Corscience has joined AdvaMed, the Advanced Medical Technology Association – the world’s leading MedTech trade organization. With this move, Corscience aligns itself with AdvaMed’s mission to improve global access to safe, affordable and high-performance medical technologies.


As a provider of highly specialized OEM modules and a recognized expert in defibrillation and vital sign monitoring, Corscience contributes deep technical expertise and extensive regulatory experience, particularly in MDR compliance. This perspective will add valuable insights to ongoing efforts within the association to streamline development and approval processes while opening new markets for all members.

At the same time, the company continues to push the boundaries of innovation, including ambitious miniaturization projects such as the world’s smallest AED. With interdisciplinary teams of hardware and software specialists, including members of standards committees, Corscience will be a strong partner and valuable resource for the association.

“Joining AdvaMed is a natural next step in our commitment to shaping the future of medical technology,” said Dr. Jörg Pintaske, CEO of Corscience. “As the world turns inward, we are committed to fostering global collaboration and shaping a visionary MedTech ecosystem. We’re eager to share our expertise, build synergies, and support AdvaMed’s vital role in advancing opportunities for meaningful innovation.”

Scott Whitaker, President and CEO of AdvaMed, welcomes Corscience to the association, emphasizing the importance of MedTech alliances: “Corscience’s track record demonstrates how international expertise fuels breakthrough innovation. Their engineering and regulatory strengths make them a valuable addition to our global mission. Partners like Corscience show that worldwide collaboration is the key to advancing life-saving technologies and improving patient outcomes.”

About Corscience GmbH & Co. KG

Corscience is the right partner for defibrillation, monitoring, and critical care. We help medical device manufacturers bring safer products to market faster. We offer high-quality medical technology, customizable modular solutions, and consulting services. Drawing on decades of technology expertise, our customers benefit from a fully integrated value chain – from the idea to market with regulatory approval and lifecycle management. With around 100 employees at our headquarters in Erlangen, Germany, we have already successfully completed more than 300 projects for partners in Europe, Asia and the USA.

To learn more, visit www.corscience.com

Contacts

Thomas Friedrich

Product Marketing Manager

Thomas.friedrich@corscience.com

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

23 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

23 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

23 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

23 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

23 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

23 hours ago